Somnomed shares see significant block trade, TDM Growth Partners reduces stake

Somnomed Limited announced a block trade of 16,071,430 shares at A$0.70 per share, successfully completed on September 16, 2025. This transaction involved 2,860,000 shares from the SomnoMed employee share trust and 13,211,430 shares from TDM Growth Partners. The sale reduced TDM Growth Partners' relevant interest in Somnomed from 31.3% to 25.0%. TDM has also agreed to a restriction on selling further shares until after the interim results announcement in February 2026.

This strategic move, supported by both Somnomed and TDM, aims to diversify the company's share register and enhance free float and liquidity. The transaction provided investor access without diluting existing shareholders, attracting new and existing institutional and retail shareholders. Prior to this change, TDM Growth Partners held 67,716,079 ordinary shares and 300,000 options, which has now decreased to 54,504,649 ordinary shares and 300,000 options.

Benjamin Gisz, a director of Somnomed, holds an indirect relevant interest through TDM Growth Partners Pty Ltd, which controls the disposal of client shareholdings. Following the block trade, his indirect holding of ordinary shares also decreased by 13,211,430, reflecting the overall reduction in TDM's stake.